SOZO

SOZO youtube hits has exceed 105k views within 3 days from Friday. This has been a pretty good launch from marketing point of view. What we need now is to see this to go exponential to millions of views and generate excitement from both Wellness and Health sectors.

The successful launch of this product to address the CHF market and Lymphedema market will be sufficient to push this share price easily to the $2 mark in my opinion. I am waiting in anticipation of the September conclusion of the testing of this device by Vanderbilt and eventually seeing the approval of this product by FDA within FY17. Hopefully it's a speedy approval with the technology behind it being the same as L-Dex, i.e. bioimpedance.

If we can then start to move into nephrology space and sports performance measurement space, pretty much the sky is the limit for this company!